BEFESA S.A. (0RVK)
London Exchange · UK · prices in EUR · close of 21 Oct 2026
Key indicators
| Last close | EUR 33.03 |
|---|---|
| 52-week range | 25.86 – 38.10 |
| Return, 1 month / 3 months | −3.3% / −4.4% |
| Return, 1 year / 3 years | +14.1% / +24.5% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 36 |
| Volatility (1 year) | 32.4% |
| Worst drawdown (1 year) | -18.3% |
| Average daily value traded | 0.67M EUR |
| Dividend yield | 3.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Befesa is a Spanish environmental services company that focuses on recycling residues from the steel and aluminium industries. It collects dust and other by-products from steelmakers and processors, recovers metals such as zinc, and turns the remaining material into products used in construction and other industries. The company also provides industrial waste treatment and hazardous waste management services, serving manufacturers and metal producers across Europe and other regions from its base in Spain.
BEFESA S.A. trades under the code 0RVK on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
BEFESA S.A. (0RVK) trades on the London Exchange in UK. It last closed at EUR 33.03 on 21 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 1,612 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 14.1% and over the last three months it fell 4.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 60 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.4% | ||
| From 52-week high | -12.6% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -4.4% | ||
| 6-month return | -1.9% | ||
| 12-month return, skipping the last month | 18.0% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 32.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.3% | ||
| Liquidity | 48 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.67M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 57 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.0% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −4.6% |
|---|---|
| 1 month | −3.3% |
| 3 months | −4.4% |
| 6 months | −1.9% |
| 1 year | +14.1% |
| 3 years | +24.5% |
| 5 years | – |
Signals
| 50-day / 200-day average | 35.30 / 32.90 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.98 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Jun 2026 | EUR 1.0000 |
| 20 Jun 2025 | EUR 0.6400 |
| 21 Jun 2024 | EUR 0.7300 |
| 16 Jun 2023 | EUR 1.2500 |
| 17 Jun 2022 | EUR 1.2500 |
| 1 Jul 2021 | EUR 1.1700 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.